VanEck Associates’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $35K | Buy |
|
|||||
|
2020
Q2 | $34K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $34K | Buy |
|
|||||
|
2018
Q4 | $23K | Buy |
|
|||||
|
2018
Q3 | $41K | Buy |
|
|||||
|
2018
Q2 | $23K | Buy |
|
|||||
|
2018
Q1 | $20K | Buy |
|
|||||
|
2017
Q4 | $23K | Sell |
|
|||||
|
2017
Q3 | $24K | Buy |
|
|||||
|
2017
Q2 | $33K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $90K | Buy |
|
|||||
|
2015
Q4 | $108K | Buy |
|
|||||
|
2015
Q3 | $79K | Buy |
|
|||||
|
2015
Q2 | $114K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $97K | Buy |
|
|||||
|
2013
Q2 | $49K | Buy |
|